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Background
Renal allograft recipients, as for HIV/AIDS patients, have a
well-documented increased incidence of human papillo-
mavirus (HPV)-related malignancies and preventive strate-
gies should be specifically implemented. While in females
the use of the Papanicolau test and HPV detection assay
are used currently as a screening test for cervical cancer,
no diagnostic procedures have been implemented to
monitor HPV infection in males. The aim of this study
was to test for HPV infection and to determine the spec-
trum of viral genotypes in urine samples of men with
renal transplants.
Material and methods
The study included 103 patients who underwent kidney
transplantation between 1999 and 2008. HPV sequences
were detected by nested PCR, using the broad-spectrum
consensus- primer pairs MY09/MY11 and the new
MGP system, and characterized by nucleotide sequence
analysis.
Results
Overall, 49 (47.5%) samples were found positive for
HPV sequences and the most common genotypes were
HPV 16 (51.0%) and HPV 54 (10.2%) followed by HPV6,
5 3 ,5 6 ,5 8 ,6 6 ,1 1 ,1 2 ,2 0 ,4 5 ,6 2 ,a n d7 1 ,i nd e s c e n d i n g
o r d e ro fp r e v a l e n c e( T a b l e1 ) .T h em a j o r i t yo fH P V1 6
isolates were classified as European and only two as
African-1 variant on the basis of nucleotide signature
present within the MGP L1 region.
Conclusion
The high prevalence of HPV 16 among renal allograft
recipients suggests that an HPV-16-based preventive or
therapeutic vaccine may be effective for prevention or
treatment of HPV-related neoplasia in this group of
immune compromised patients.
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Table 1 Prevalence of HPV genotypes in renal transplant
patients
HPV genotype
a HPV positive, n (%)
HPV positive 49 (47.5)
HPV negative 54 (52.4)
Single infections
16 25 (51.0)
56 2 (4.0)
58 1 (2.0)
54 5 (10.2)
6 2 (4.0)
11 1 (2.0)
12 1 (2.0)
20 1 (2.0)
53 1 (2.0)
62 1 (2.0)
66 1 (2.0)
71 1 (2.0)
Total single infections 42 (85.7)
Total multiple infections 4 (8.2)
Undetermined 3 (6.1)
aGray shadow indicates HPV genotypes defined by IARC working group as
class I carcinogens for humans [Bouvard et al., Lancet Oncol 10:321–322,
2009]
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